BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35421639)

  • 1. Cross-sectional and longitudinal correlations between the Arm Function in Multiple Sclerosis Questionnaire (AMSQ) and other outcome measures in multiple sclerosis.
    Molenaar PCG; Strijbis EMM; van Munster CEP; Uitdehaag BMJ; Kalkers NF
    Mult Scler Relat Disord; 2022 May; 61():103725. PubMed ID: 35421639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian validation of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ).
    Tacchino A; Ponzio M; Pedullà L; Podda J; Bragadin MM; Pedrazzoli E; Konrad G; Battaglia MA; Mokkink L; Brichetto G
    Neurol Sci; 2020 Nov; 41(11):3273-3281. PubMed ID: 32394274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement properties of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ): a study based on Classical Test Theory.
    van Leeuwen LM; Mokkink LB; Kamm CP; de Groot V; van den Berg P; Ostelo RWJG; Uitdehaag BMJ
    Disabil Rehabil; 2017 Oct; 39(20):2097-2104. PubMed ID: 27665841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries.
    Kalkers NF; Galan I; Kerbrat A; Tacchino A; Kamm CP; O'Connell K; McGuigan C; Edan G; Montalban X; Uitdehaag BM; Mokkink LB
    Mult Scler; 2021 Jan; 27(1):90-96. PubMed ID: 31845614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis.
    van 't Hullenaar CAA; Coerver E; Kalkers NF; van Kempen Z; Koch M; Uitdehaag BMJ; Killestein J; Strijbis EMM
    Mult Scler Relat Disord; 2021 Oct; 55():103165. PubMed ID: 34404022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responder rates to fampridine differ between clinical subgroups of MS patients and patient reported outcome influences treatment decision making.
    van Munster CEP; Kaya L; Lam KH; Kalkers NF; Killestein J; Uitdehaag BMJ
    Mult Scler Relat Disord; 2020 Feb; 38():101489. PubMed ID: 31731213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between patient-reported manual ability and three objective measures of upper limb function in people with multiple sclerosis.
    Solaro C; Di Giovanni R; Grange E; Brichetto G; Mueller M; Tacchino A; Bertoni R; Patti F; Pappalardo A; Prosperini L; Castelli L; Rosato R; Cattaneo D; Marengo D
    Eur J Neurol; 2023 Jan; 30(1):172-178. PubMed ID: 36086993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-cultural adaptation and psychometric properties of the Turkish version of the Manual Ability Measure-36 (MAM-36) in people with multiple sclerosis.
    Ertekin O; Kahraman T; Aras M; Baba C; Ozakbas S
    Neurol Sci; 2021 Jul; 42(7):2927-2936. PubMed ID: 33236246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tasks of activities of daily living (ADL) are more valuable than the classical neurological examination to assess upper extremity function and mobility in multiple sclerosis.
    van Munster CE; D'Souza M; Steinheimer S; Kamm CP; Burggraaff J; Diederich M; Kravalis K; Dorn J; Walsh L; Dahlke F; Kappos L; Uitdehaag BM
    Mult Scler; 2019 Oct; 25(12):1673-1681. PubMed ID: 30168739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the Arm Function in Multiple Sclerosis Questionnaire-Short Form (AMSQ-SF): A static 10-item version.
    Luijten MA; Eekhout I; D'Hooghe M; Uitdehaag BM; Mokkink LB
    Mult Scler; 2018 Dec; 24(14):1892-1901. PubMed ID: 30411658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal clinically important difference of improvement on the Arm Function in Multiple Sclerosis Questionnaire (AMSQ).
    van Munster CE; Kaya L; Obura M; Kalkers NF; Uitdehaag BM
    Mult Scler; 2020 Apr; 26(4):505-508. PubMed ID: 30657002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic.
    Bethoux FA; Palfy DM; Plow MA
    Int J Rehabil Res; 2016 Jun; 39(2):134-9. PubMed ID: 26926380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the impact of upper limb tremor on the quality of life of people with multiple sclerosis: a comparison between the QUEST and MSIS-29 scales.
    Tang CC; Soh SE; Boonstra F; Noffs G; Kolbe SC; Butzkueven H; Evans A; Van der Walt A
    Mult Scler Relat Disord; 2022 Feb; 58():103495. PubMed ID: 35085981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis impairment scale and brain MRI in secondary progressive multiple sclerosis.
    Theodorsdottir A; Larsen PV; Nielsen HH; Illes Z; Ravnborg MH
    Acta Neurol Scand; 2022 Mar; 145(3):332-347. PubMed ID: 34799851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nine Hole Peg Test asymmetry in refining upper limb assessment in multiple sclerosis.
    Solaro C; Grange E; Di Giovanni R; Cattaneo D; Bertoni R; Prosperini L; Messmer Uccelli M; Marengo D
    Mult Scler Relat Disord; 2020 Oct; 45():102422. PubMed ID: 32731199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and relation of two arm function tests, Box and Blocks test and Nine Hole Peg test, across disease severity levels and types of multiple sclerosis.
    Bertoni R; Cattaneo D; Grosso C; Baglio F; Jonsdottir J
    Mult Scler Relat Disord; 2022 Mar; 59():103683. PubMed ID: 35168094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian translation and psychometric validation of the ABILHAND-26 and its correlation with upper limb objective and subjective measures in multiple sclerosis subjects.
    Grange E; Marengo D; Di Giovanni R; Mueller M; Brichetto G; Tacchino A; Bertoni R; Patti F; Pappalardo A; Prosperini L; Castelli L; Rosato R; Cattaneo D; Solaro C
    Mult Scler Relat Disord; 2021 Oct; 55():103160. PubMed ID: 34320388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Box and block test, hand grip strength and nine-hole peg test: correlations between three upper limb objective measures in multiple sclerosis.
    Solaro C; Di Giovanni R; Grange E; Mueller M; Messmer Uccelli M; Bertoni R; Brichetto G; Tacchino A; Patti F; Pappalardo A; Prosperini L; Castelli L; Rosato R; Cattaneo D; Marengo D
    Eur J Neurol; 2020 Dec; 27(12):2523-2530. PubMed ID: 32619066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technology-enabled comprehensive characterization of multiple sclerosis in clinical practice.
    Baldassari LE; Nakamura K; Moss BP; Macaron G; Li H; Weber M; Jones SE; Rao SM; Miller D; Conway DS; Bermel RA; Cohen JA; Ontaneda D; McGinley MP
    Mult Scler Relat Disord; 2020 Feb; 38():101525. PubMed ID: 31759186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Arm Function in Multiple Sclerosis Questionnaire (AMSQ): development and validation of a new tool using IRT methods.
    Mokkink LB; Knol DL; van der Linden FH; Sonder JM; D'hooghe M; Uitdehaag BMJ
    Disabil Rehabil; 2015 Dec; 37(26):2445-2451. PubMed ID: 25801923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.